A detailed history of Firestone Capital Management transactions in Abbott Laboratories stock. As of the latest transaction made, Firestone Capital Management holds 1,785 shares of ABT stock, worth $206,881. This represents 0.05% of its overall portfolio holdings.

Number of Shares
1,785
Holding current value
$206,881
% of portfolio
0.05%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$100.07 - $118.13 $178,624 - $210,862
1,785 New
1,785 $203,000
Q1 2024

May 07, 2024

BUY
$109.52 - $120.96 $195,493 - $215,913
1,785 New
1,785 $202,000
Q4 2021

Feb 11, 2022

SELL
$115.53 - $141.46 $90,691 - $111,046
-785 Closed
0 $0
Q4 2019

Feb 13, 2020

BUY
$78.51 - $87.4 $45,143 - $50,255
575 Added 273.81%
785 $68,000
Q4 2019

Feb 10, 2020

BUY
$78.51 - $87.4 $16,487 - $18,354
210 New
210 $68,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $203B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Firestone Capital Management Portfolio

Follow Firestone Capital Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Firestone Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Firestone Capital Management with notifications on news.